CYCLERION THERAPEUTICS, INC. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount
CYCLERION THERAPEUTICS, INC. (CYCN) had Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossCumulativeAmount · last filed 2026-08-04
- 2026-06-30: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $0.00.
- 2026-03-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $0.00.
- 2025-12-31: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $0.00.
- 2025-09-30: Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Cumulative Amount |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 |
| 2026-03-31 | $0.00 S-4/A · filed 2026-07-22 |
| 2025-12-31 | $0.00 S-4/A · filed 2026-07-22 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-K/A · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |